Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05242900 · ClinicalTrials.gov registry record
Imaging Sodium and Lymphatics in Lymphedema
A clinical trial of Lymphedema, Secondary and Lymphedema of Leg, sponsored by University of Virginia.
- Active
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT05242900 is a study of Lymphedema, Secondary and Lymphedema of Leg that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05242900, a study of Lymphedema, Secondary and Lymphedema of Leg, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent evidence supports lymphatic regulation of tissue sodium handling, however fundamental gaps persist in knowledge regarding the role of lymphatics in human diseases of sodium dysregulation. The goal of this work is to apply novel, noninvasive imaging tools to measure relationships between lymphatic function and tissue sodium in patients with well-characterized lymphedema. Findings are intended to inform mechanisms of lymphatic clearance of tissue sodium, and provide novel imaging biomarkers of lymphedema progression and treatment response.
Conditions Studied
Interventions
- PROCEDURE Complete decongestive therapy
- OTHER Standard imaging protocol
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-10-10 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05242900
The ClinicalTrials.gov registry entry for NCT05242900 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lymphedema, Secondary appearing as the primary indexed condition, and to 2 interventions - of which Complete decongestive therapy is the first listed.
NCT05242900 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05242900 about?
NCT05242900 is a clinical study titled "Imaging Sodium and Lymphatics in Lymphedema". Recent evidence supports lymphatic regulation of tissue sodium handling, however fundamental gaps persist in knowledge regarding the role of lymphatics in human diseases of sodium dysregulation. The goal of this work is to apply novel, noninvasive imaging tools to measure relationships between lymph...
What is the current status of trial NCT05242900?
This trial is currently active not recruiting. The enrollment target is 75 participants. The study started on 2021-10-10. Estimated completion is 2025-12.
What conditions does trial NCT05242900 study?
This clinical trial studies the following conditions: Lymphedema, Secondary, Lymphedema of Leg, Lymphedema Related Fibrosis.
What interventions are being tested in trial NCT05242900?
The interventions under investigation include: Complete decongestive therapy (PROCEDURE), Standard imaging protocol (OTHER).
Who is sponsoring clinical trial NCT05242900?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05242900 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema, Secondary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.